Selected publications

Frank C, Fallah M, Chen T, Mai EK, Sundquist J, Försti A, Hemminki K. Search for familial clustering of multiple myeloma with any cancer. Leukemia 2016;30:627-32 .

Hemminki K, Försti A, Sundquist K, Sundquist J  and Li L. Familial associations of monoglonal gammopathy of unknown significance (MGUS) with autoimmune diseases. Leukemia 2016; 3:1766-9.IF 12.1.

Mitchell JS, Li L, Weinhold N, Försti A, Ali M, van Duin M, Thorleifsson G, Johnson DC, Chen B, Halvarsson BM, Gudbjartsson DF, Kuiper R, Stephens OW, Bertsch U, Broderick P, Campo C, Einsele H, Gregory WA, Gullberg U, Henrion M, Hillengass J, Hoffmann P, Jackson GH, Johnsson E, Jöud M, Kristinsson SY, Lenhoff S, Lenive O, Mellqvist UH, Migliorini G, Nahi H, Nelander S, Nickel J, Nöthen MN, Rafnar T, Ross FM, da Silva Filho MI, Swaminathan B, Turesson I, Vangsted A, Vogel U, Waage A, Walker BA, Wihlborg AK, Broyl A, Davies FE, Thorsteinsdottir U, Langer C, Hansson M, Kaiser M, Sonneveld P, Stefansson K*, Morgan GJ*, Goldschmidt H*, Hemminki K*, Nilsson B*, Houlston RS*. Genome-wide association study identifies multiple susceptibility loci for multiple myeloma. Nature Communications 2016; 7:12050. (*=equal contribution).

Li N, Johnson D, Weinhold N, Studd J, Orlando G, Mirabella F, Mitchell J, Meissner T, Kaiser M, Goldschmidt H, Hemminki K, Morgan GJ, Houlston R. Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression. Nature Commun 2016; 7:13656.  

Vijayakrishnan J, Kumar R, Henrion MY, Moorman AV, Rachakonda PS, Hosen I, da Silva Filho MI, Holroyd A, Dobbins SE, Koehler R, Thomsen H, Irving JA, Allan JM, Lightfoot T, Roman E, Kinsey SE, Sheridan E, Thompson PD, Hoffmann P, Nöthen MM, Heilmann-Heimbach S, Karl-Heinz J, Greaves M, Harrison CJ, Bartram CR, Schrappe M, Stanulla M, Hemminki K, Houlston RS. A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1. Leukemia 2017; 31:573-579.

da Silva Filho MI, Försti A, Weinhold N, Meziane I, Campo C, Huhn S, Nickel J, Hoffmann P, Nöthen MM, Jöckel KH, Landi S, Mitchell JS, Johnson D, Morgan GJ, Houlston R, Goldschmidt H,  Jauch A, Milani P, Merlini G, Rowcieno D, Hawkins P, Hegenbart U, Palladini G, Wechalekar A, Schönland SO*, Hemminki K *. Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison to myeloma. Leukemia 2017 in press (*=equal contribution).

Sud A, Thomsen H, Sundquist K, Houlston RS, Hemminki K. Risk of second cancer in Hodgkin lymphoma survivors and the influence of family history. J Clin Oncol 2017; in press

to top